Product Images Cyclophosphamide

This is a pharmaceutical label for a vial of cyclophosphamide containing 500mg. It provides information on recommended dosage, dilution instructions, and storage conditions. The drug is designated as hazardous and must be refrigerated. The vial is manufactured for Avyxa Pharma, LLC.*

This is a description of a medication called Cyclophosphamide Injection, with a concentration of 500 mg/mL. The drug is manufactured for Hyca Pharma, LLC in New Jersey, USA, and is made in India. Each vial contains 500 mg of cyclophosphamide and 500 mg of dehydrated alcohol. It is a hazardous drug and should be diluted before intravenous use. The recommended diluents are 0.45% Sodium Chloride Injection, 5% Dextrose Injection, or a combination of 5% Dextrose and 0.9% Sodium Chloride Injection. The vials should be stored refrigerated at 2°C to 8°C. The J Code for this product is J9072.*

This is a description for a medication vial containing Cyclophosphamide, with a recommended dosage for injection. The text also provides information on the dilution process before intravenous use. The product is intended for single-dose vial use and must be stored refrigerated between 2°C to 8°C. Produced by Avyxa Pharma, LLC and manufactured in India.*

This is a description of a medication product called Cyclophosphamide Injection, manufactured by Huyca Pharma, LLC in New Jersey, USA. It is made in India and comes in single-dose vials, each containing 1g of cyclophosphamide. The recommended dosage should be followed as per the prescribing information. It is essential to dilute before intravenous use with specific solutions mentioned in the text. This drug is classified as hazardous, and unused portions should be discarded. Storage should be in a refrigerated environment between 2°C to 8°C (36°F to 46°F). The J Code for this product is J9072.*

This text appears to be a prescription for the medication cyclophosphamide, including information on recommended dosage, dilution, storage, and manufacturer details. It also mentions the specific types of solutions that should be used for diluting the medication before intravenous infusion. Additionally, it highlights the importance of caution and provides guidance on the handling and storage of the product.*

This text provides information on a medication called Cyclophosphamide Injection, which is manufactured for Avyxa Pharma, LLC in USA but made in India. The medication comes in single-dose vials containing 2 grams of Cyclophosphamide per 4 mL (500 mg/mL) and must be diluted before intravenous use. It is classified as a hazardous drug and should be stored refrigerated at 2°C to 8°C. The text includes a code number, dosage recommendations, and instructions for dilution with specific types of injectable solutions.*